Combined, these data indicate that the majority of CTCs found in metastatic breast cancer patients maintain a stem-like (CD44+/CD24−) state, while staying mitotically inactive; whereas a smaller sub-population of CTCs are of an epithelial (PanCK+) phenotype, with a higher proliferative index. This evidence concerns the gene CD44 and breast carcinoma.